Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$230M |
| 2 |
Johnson & Johnson
JNJ
|
+$205M |
| 3 |
Bank of America
BAC
|
+$163M |
| 4 |
Costco
COST
|
+$162M |
| 5 |
GSK
GSK
|
+$131M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$396M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$219M |
| 3 |
GE Aerospace
GE
|
+$156M |
| 4 |
Walt Disney
DIS
|
+$154M |
| 5 |
Amazon
AMZN
|
+$138M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.36% |
| 2 | Healthcare | 13.06% |
| 3 | Consumer Discretionary | 12.03% |
| 4 | Consumer Staples | 11.17% |
| 5 | Industrials | 10.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1876
CrossAmerica Partners
CAPL
$831M
| $1.54M | ﹤0.01% |
+53,818
| New | +$1.5M |
|
|
KYTH
1877
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
| $1.54M | ﹤0.01% |
+41,200
| New | +$1.71M |
|
|
CUB
1878
DELISTED
Cubic Corporation
CUB
| $1.54M | ﹤0.01% |
+29,200
| New | +$1.54M |
|
1879
Financial Institutions
FISI
$812M
| $1.53M | ﹤0.01% |
62,100
-4,200
| -6% | -$97.9K |
|
|
PRSU
1880
Pursuit Attractions and Hospitality Inc
PRSU
$1.4B
| $1.53M | ﹤0.01% |
58,648
-48,593
| -45% | -$1.16M |
|
1881
Broadwind
BWEN
$91.3M
| $1.53M | ﹤0.01% |
162,220
-53,371
| -25% | -$415K |
|
1882
Clearway Energy Class C
CWEN
$4.94B
| $1.52M | ﹤0.01% |
+76,200
| New | +$1.36M |
|
|
SAND
1883
DELISTED
Sandstorm Gold
SAND
| $1.52M | ﹤0.01% |
+356,400
| New | +$1.71M |
|
|
PDH
1884
DELISTED
PETROLOGISTICS LP UNIT LTD PARTNERSHIP INT
PDH
| $1.52M | ﹤0.01% |
130,637
+72,364
| +124% | +$863K |
|
1885
American Superconductor
AMSC
$1.43B
| $1.52M | ﹤0.01% |
92,737
+62,850
| +210% | +$1.17M |
|
1886
Turkcell
TKC
$4.72B
| $1.52M | ﹤0.01% |
113,919
+4,400
| +4% | +$66.5K |
|
1887
Escalade
ESCA
$288M
| $1.51M | ﹤0.01% |
128,300
+36,804
| +40% | +$364K |
|
1888
Horizon Bancorp
HBNC
$1.05B
| $1.5M | ﹤0.01% |
133,400
+3,687
| +3% | +$37.4K |
|
1889
Belden
BDC
$4.56B
| $1.5M | ﹤0.01% |
+21,300
| New | +$1.44M |
|
1890
Bristow Group
VTOL
$1.32B
| $1.5M | ﹤0.01% |
+24,250
| New | +$1.5M |
|
|
FBMI
1891
DELISTED
FIRSTBANK CORP (MICH)
FBMI
| $1.5M | ﹤0.01% |
77,355
+14,354
| +23% | +$275K |
|
|
ADAM
1892
Adamas Trust
ADAM
$803M
| $1.5M | ﹤0.01% |
+53,475
| New | +$1.43M |
|
1893
Erie Indemnity
ERIE
$12.2B
| $1.48M | ﹤0.01% |
20,271
+6,097
| +43% | +$435K |
|
|
TELL
1894
DELISTED
Tellurian Inc.
TELL
| $1.48M | ﹤0.01% |
179,475
-19,175
| -10% | -$160K |
|
|
INN
1895
Summit Hotel Properties
INN
$748M
| $1.48M | ﹤0.01% |
164,059
+127,559
| +349% | +$1.15M |
|
|
CXDC
1896
DELISTED
China XD Plastics Company Limited
CXDC
| $1.47M | ﹤0.01% |
279,900
+21,900
| +8% | +$107K |
|
|
CMD
1897
DELISTED
Cantel Medical Corporation
CMD
| $1.47M | ﹤0.01% |
43,350
+32,400
| +296% | +$1.12M |
|
|
EARN
1898
Ellington Residential Mortgage REIT
EARN
$168M
| $1.47M | ﹤0.01% |
+95,400
| New | +$1.49M |
|
|
RSE
1899
DELISTED
ROUSE PPTYS INC COM (DE)
RSE
| $1.47M | ﹤0.01% |
66,100
-1,600
| -2% | -$34.1K |
|
|
OKSB
1900
DELISTED
Southwest Bancorp Inc/OK
OKSB
| $1.47M | ﹤0.01% |
92,033
+51,477
| +127% | +$813K |
|
Similar funds
Renaissance Technologies's Q4 2013 Portfolio in Review
As of Q4 2013, Renaissance Technologies held 3,281 positions worth $41.8B, up 1.3% from $41.2B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies withdrew a net $2.31B in Q4 2013, closing 464 positions and reducing 983 holdings. Its most notable exit was GE Aerospace, an estimated $156M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Renaissance Technologies opened a new position in Pfizer worth $230M.
- Renaissance Technologies's largest Q4 2013 buy was Pfizer: 7,904,832 shares worth $230M.
- Renaissance Technologies added most to Johnson & Johnson in Q4 2013, an estimated $205M increase.
- Renaissance Technologies's biggest Q4 2013 reduction was IBM, cutting an estimated $396M.
- Renaissance Technologies fully exited GE Aerospace in Q4 2013, selling an estimated $156M.
- Renaissance Technologies's ten largest holdings make up 11% of its $41.8B portfolio in Q4 2013.
- Renaissance Technologies opened 498 new positions and closed 464 in Q4 2013.
- Renaissance Technologies's portfolio value rose 1.3% quarter-over-quarter to $41.8B.
Based on Renaissance Technologies's 13F filing for Q4 2013, filed 14 Feb 2014.